Thiel-backed CEO eyes $50M fundraise after bagging China drug
Ashlins Pharma has licensed a Chinese formulation of a well-known medicine and set its sights on a $50 million fundraise.
Ashlins Pharma
Private
Ashlins Pharma is a rare disease startup that has licensed a Chinese formulation of a well-known medicine and is pursuing a $50 million fundraise. Backed by Peter Thiel.
Company Info
Sector:Rare Disease
Headquarters:USA
Founded:2024
Website:ashlinspharma.com/
Funding Round:Seed/Series A
Total Funding:$31M raised (July 2026)
Funding & Investor Relations
Notable Investors
- Peter Thiel (backing)
Upcoming Milestones & Key Dates
2026 H2
Financing
$50M Series A fundraise
Clinical Development Pipeline
Licensed China drug
Target: TBDUndisclosed
Target: TBDUndisclosed
Target: TBDRecent News
Leadership Team
To be confirmed
Chief Executive Officer
To be confirmed
Chief Medical Officer
To be confirmed
Chief Scientific Officer